Health in South Sudan 1,040 indicators covering health for South Sudan. IndicatorLatest Year10-yr change Rank Concentrations of fine particulate matter 23.49 2023 down 3.7% 72nd Death rate road traffic injuries 36.7 2019 up 45.1% 7th New or unknown treatment history cases: Pulmonary, bacteriologically 12,075 2023 up 298.8% 38th Constant stillbirth rate 27.65 2030 unchanged 8th ENAP target met stillbirth rate 12 2030 down 51.1% 1st Stillbirth rate high-income country 2.8 2030 down 86.0% 1st Stillbirths remain constant projection 11,244 2030 up 13.3% 34th Stillbirth maintained projection 10,100 2030 up 3.4% 34th Stillbirth ENAP 2030 target met projection 4,803 2030 down 45.3% 48th Stillbirth high-income country average rate matched projection 1,110 2030 down 84.4% 61st Stillbirth rate current trends 24.91 2030 down 8.6% 6th Life satisfaction vs life expectancy 57.62 2023 down 1.1% 225th Tb patients tested positive for hiv 2,090 2021 up 388.3% 28th Number of children aged 6-59 months with anaemia 1,027 2019 up 10.7% 45th Prevalence of anaemia in children aged 6-59 months 60.5% 2019 up 0.2% 22nd Number of deaths attributed to non-communicable diseases, by type of 6,275 2019 up 26.4% 109th Hepatitis B surface antigen (HBsAg) prevalence 1.7% 2024 down 64.6% 17th Mortality caused by road traffic injury 36.7 per 100,000 population 2019 up 52.9% 7th Mortality caused by road traffic injury, female 24.5 per 100,000 female population 2019 up 54.1% 2nd Mortality caused by road traffic injury, male 49 per 100,000 male population 2019 up 52.6% 15th Mean hemoglobin level of children aged 6-59 months 105 2019 up 1.0% 171st Estimated number of MDR/RR-TB incident cases 780 2024 down 35.0% 40th Neonatal mortality rate - Remains constant 39.47 2030 unchanged 1st Neonatal mortality rate - Current trends maintained 39.47 2030 unchanged 1st Neonatal mortality rate - High-income country average rate matched 2.8 2030 down 89.0% 1st Neonatal mortality rate - SDG target met 12 2030 down 62.9% 1st Under 5 mortality rate - Remains constant 96.71 2030 unchanged 5th Under 5 mortality rate - Current trends maintained 96.67 2030 down 0.0% 3rd Under 5 mortality rate - High-income country average rate matched 5.09 2030 down 91.4% 1st Under 5 mortality rate - SDG target met 25 2030 down 67.6% 1st Mortality rate age 10-19 - Remains constant 23.36 2030 unchanged 2nd Mortality rate age 10-19 - Current trends maintained 23.36 2030 unchanged 1st Mortality rate age 10-19 - High-income country average rate matched 5.66 2030 down 62.9% 2nd Neonatal deaths - Remains constant 15,592 2030 up 10.6% 34th Neonatal deaths - Current trends maintained 15,592 2030 up 10.6% 29th Neonatal deaths - SDG target met 4,742 2030 down 59.0% 48th Under-five deaths - Remains constant 37,148 2030 up 11.9% 30th Under-five deaths - Current trends maintained 37,133 2030 up 11.9% 28th Under-five deaths - SDG target met 9,652 2030 down 63.5% 46th Deaths age 10 to 19 - Remains constant 7,278 2030 down 2.8% 32nd Deaths age 10 to 19 - Current trends maintained 7,272 2030 down 2.9% 32nd Ipv vaccine coverage 67 2024 up 2,133.3% 176th Deaths in armed conflicts by country, annual growth rate -79.74 % change on previous year 2026 down 614.4% 13th Deaths in armed conflicts by region, annual growth rate -79.74 % change on previous year 2026 down 614.4% 13th Tb patients living with hiv receiving art 2,005 2021 up 1,643.5% 27th HIV-positive TB patients on ART (antiretroviral therapy) 97.0% 2024 up 56.5% 69th Treatment success rate for patients treated for MDR-TB 94.0% 2022 up 6.8% 19th New leprosy case detection rate per 1 000 000 population 46.72 2024 down 20.6% 17th Treatment success rate: HIV-positive TB cases 76 2023 up 22.6% 69th Estimated number of children (aged 0-17 years) who have lost one or 830,000 2024 up 18.6% 33rd Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 34.0% 2025 — 164th International Health Regulations core capacity scores, SPAR version 50 2025 — 85th Leprosy registered prevalence rate per 1 000 000 population 50.99 2024 down 17.8% 16th Leprosy - Number of new leprosy cases among children 35 2024 down 49.3% 21st Leprosy - Number of cases registered for treatment 609 2024 down 16.3% 20th New leprosy child case detection rate (less than 15 years of age) per 7.53 2024 down 51.2% 18th Children (0-14) living with HIV 11,000 2024 down 45.0% 17th Ipv1 number unvaccinated 100,514 2023 down 71.8% 37th Children living with hiv 11,000 2024 down 45.0% 17th Children (ages 0-14) newly infected with HIV 1,100 2024 down 65.6% 19th ← Previous Page 16 of 18 Next →